Industry Leaders

51. Personalizing The Work Of Life Sciences Organizations 7/7/2017

    Many parents can tell a story about the lengths they’ve gone to help their children when no doctor could provide an answer. But there’s one story that stands out to me above the rest because it really drives home the vital need for data sharing, digital collaboration, and the establishment of a connected health ecosystem in the life sciences industry.

52. 5 Areas To Focus On To Improve Drug Development Productivity 7/7/2017

    Much has been written about opportunities for improving the drug development process. Although there are many areas ripe for process improvements, let’s focus on the following five.

53. Considerations For The Use Of Wearables In Clinical Trials 2/1/2017

    With wearables, we now have the means to innovate the “where” and the “how” of patient data capture, creating a 24-hour digital map of physical behaviors.

54. How Patients Will Revolutionize Next-Generation Clinical Research 2/1/2017

    Often when we think about inefficiencies in the clinical trial process, we focus on the role of the sponsor or CRO, a particular aspect of the value chain, or new technologies that promote data sharing and faster decision making. While these are critical aspects that drive day-to-day operations, there is another aspect of the value chain that we may be neglecting: the patient side.

55. How To Increase Productivity Via Unconventional Hiring 1/1/2017

    One of the most vexing and common problems HR professionals face is acquiring and training talent for specific skilled positions, only to see that talent, and the time and money invested in them, walk out the door too soon.

56. Meeting The Unknown Need In Pharma Labs 1/1/2017

    The very nature of many scientific processes creates habitual behaviors. Often these habits are effectively passed from senior lab generations to younger ones. Old habits can be hard to break, especially in a time-pressured lab environment.

57. Active Targeting: A New Wave In Drug Delivery 11/1/2016

    Although the history of drug development contains many stories of serendipitous discovery, critical advances often emerge by setting out to address specific challenges. Today, many challenges associated with older drugs are being solved with new delivery technologies.

58. The Space Squeeze: One Challenge In Building A Biopharm Lab 11/1/2016

    Any biotech or life sciences company in Boston — early-stage or mature — is no stranger to Kendall Square’s lab space squeeze. As the top-performing lab market in the U.S., Kendall Square is especially sought after by life sciences companies — ranging from emerging startups to Big Pharma.

59. Great Expectations For Personalized Medicine Outside Oncology 9/1/2016

    Oncology has always been the front runner in personalized medicine, so this is where targeted therapies and diagnostics have, for the most part, been focused. However, there is new activity outside this area where biomarker and targeted approaches are proving successful.

60. Life Sciences Companies Have Reason For Optimism In 2016 3/1/2016

    Even though the U.S. economy continued to strengthen in 2015, many public investors sat on the sidelines grappling with global economic and political concerns and uncertainty surrounding the Fed’s policy concerning interest rates.